Short-term Efficacy and Safety of a Latanoprost/Carteolol Fixed Combination Switched From Concomitant Therapy to in Patients With Primary Open-angle Glaucoma or Ocular Hypertension-Reference-Cited by-同舟云学术

Short-term Efficacy and Safety of a Latanoprost/Carteolol Fixed Combination Switched From Concomitant Therapy to in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Published:2018-12 Issue:12 Volume:27 Page:1175-1180
ISSN:1057-0829
Container-title:Journal of Glaucoma
language:en
Short-container-title:Journal of Glaucoma

Author:

Inoue Kenji,Shiokawa Minako,Iwasa Mayumi,Ishida Kyoko,Tomita Goji

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology

Reference17 articles.

1. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

2. Ocular hypotensive efficacy and safety of once daily carteolol alginate

3. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Tafluprost on Endothelial Function-related Molecules and Hemorheological Parameters in Patients with Primary Open-angle Glaucoma;2023-05-09

2. Topical glaucoma medications – Clinical implications for the ocular surface;The Ocular Surface;2022-10

3. Topical Medication Therapy for Glaucoma and Ocular Hypertension;Frontiers in Pharmacology;2021-12-01

4. Comparison of the 24-h efficacy and safety of fixed combination carteolol/latanoprost and timolol/latanoprost in patients with primary open-angle glaucoma and ocular hypertension: a prospective crossover study;Japanese Journal of Ophthalmology;2021-07-19

5. Comprehensive Pharmacology: Glaucoma;Reference Module in Biomedical Sciences;2021